These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 28339584

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Predictors of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement With the SAPIEN 3.
    Mauri V, Reimann A, Stern D, Scherner M, Kuhn E, Rudolph V, Rosenkranz S, Eghbalzadeh K, Friedrichs K, Wahlers T, Baldus S, Madershahian N, Rudolph TK.
    JACC Cardiovasc Interv; 2016 Nov 14; 9(21):2200-2209. PubMed ID: 27832845
    [Abstract] [Full Text] [Related]

  • 3. Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height.
    De Torres-Alba F, Kaleschke G, Diller GP, Vormbrock J, Orwat S, Radke R, Reinke F, Fischer D, Reinecke H, Baumgartner H.
    JACC Cardiovasc Interv; 2016 Apr 25; 9(8):805-813. PubMed ID: 27017367
    [Abstract] [Full Text] [Related]

  • 4. Conduction disturbances and permanent cardiac pacing after transcatheter implantation of the CoreValve aortic bioprosthesis: initial single centre experience.
    Czerwińska K, Hryniewiecki T, Oręziak A, Dąbrowski M, Michałowska I, Witkowski A, Demkow M, Stępińska J, Orłowska Baranowska E, Rużyłło W.
    Kardiol Pol; 2012 Apr 25; 70(2):121-8. PubMed ID: 22427074
    [Abstract] [Full Text] [Related]

  • 5. A Highly Predictive Risk Model for Pacemaker Implantation After TAVR.
    Maeno Y, Abramowitz Y, Kawamori H, Kazuno Y, Kubo S, Takahashi N, Mangat G, Okuyama K, Kashif M, Chakravarty T, Nakamura M, Cheng W, Friedman J, Berman D, Makkar RR, Jilaihawi H.
    JACC Cardiovasc Imaging; 2017 Oct 25; 10(10 Pt A):1139-1147. PubMed ID: 28412434
    [Abstract] [Full Text] [Related]

  • 6. Computed tomography (CT) assessment of the membranous septal anatomy prior to transcatheter aortic valve replacement (TAVR) with the balloon-expandable SAPIEN 3 valve.
    Oestreich BA, Mbai M, Gurevich S, Nijjar PS, Adabag S, Bertog S, Kelly R, Garcia S.
    Cardiovasc Revasc Med; 2018 Oct 25; 19(5 Pt B):626-631. PubMed ID: 29352699
    [Abstract] [Full Text] [Related]

  • 7. Predictors and 5-Year Clinical Outcomes of Pacemaker After TAVR: Analysis From the PARTNER 2 SAPIEN 3 Registries.
    Chen S, Dizon JM, Hahn RT, Pibarot P, George I, Zhao Y, Blanke P, Kapadia S, Babaliaros V, Szeto WY, Makkar R, Thourani VH, Webb JG, Mack MJ, Leon MB, Kodali S, Nazif TM.
    JACC Cardiovasc Interv; 2024 Jun 10; 17(11):1325-1336. PubMed ID: 38866455
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Predictors of permanent pacemaker implantation after transfemoral aortic valve implantation with the Lotus valve.
    Keßler M, Gonska B, Seeger J, Rottbauer W, Wöhrle J.
    Am Heart J; 2017 Oct 10; 192():57-63. PubMed ID: 28938964
    [Abstract] [Full Text] [Related]

  • 11. Aortic valve and left ventricular outflow tract calcium volume and distribution in transcatheter aortic valve replacement: Influence on the risk of significant paravalvular regurgitation.
    Hansson NC, Leipsic J, Pugliese F, Andersen HR, Rossi A, Simonato M, Jensen KT, Christiansen EH, Terkelsen CJ, Blanke P, Tang M, Krusell LR, Klaaborg KE, Terp K, Kennon S, Dvir D, Bøtker HE, Webb J, Nørgaard BL.
    J Cardiovasc Comput Tomogr; 2018 Oct 10; 12(4):290-297. PubMed ID: 29519754
    [Abstract] [Full Text] [Related]

  • 12. Minimizing Permanent Pacemaker Following Repositionable Self-Expanding Transcatheter Aortic Valve Replacement.
    Jilaihawi H, Zhao Z, Du R, Staniloae C, Saric M, Neuburger PJ, Querijero M, Vainrib A, Hisamoto K, Ibrahim H, Collins T, Clark E, Pushkar I, Bamira D, Benenstein R, Tariq A, Williams M.
    JACC Cardiovasc Interv; 2019 Sep 23; 12(18):1796-1807. PubMed ID: 31473236
    [Abstract] [Full Text] [Related]

  • 13. Timing of Onset and Outcome of New Conduction Abnormalities Following Transcatheter Aortic Valve Implantation: Role of Balloon Aortic Valvuloplasty.
    Campelo-Parada F, Nombela-Franco L, Urena M, Regueiro A, Jiménez-Quevedo P, Del Trigo M, Chamandi C, Rodríguez-Gabella T, Auffret V, Abdul-Jawad Altisent O, DeLarochellière R, Paradis JM, Dumont E, Philippon F, Pérez-Castellano N, Puri R, Macaya C, Rodés-Cabau J.
    Rev Esp Cardiol (Engl Ed); 2018 Mar 23; 71(3):162-169. PubMed ID: 28566243
    [Abstract] [Full Text] [Related]

  • 14. Impact of Aortomitral Continuity Calcification on Need for Permanent Pacemaker After Transcatheter Aortic Valve Replacement.
    Katchi F, Bhatt D, Markowitz SM, Szymonifka J, Cheng EP, Minutello RM, Bergman GW, Wong SC, Salemi A, Truong QA.
    Circ Cardiovasc Imaging; 2019 Dec 23; 12(12):e009570. PubMed ID: 31813271
    [Abstract] [Full Text] [Related]

  • 15. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
    Nazif TM, Dizon JM, Hahn RT, Xu K, Babaliaros V, Douglas PS, El-Chami MF, Herrmann HC, Mack M, Makkar RR, Miller DC, Pichard A, Tuzcu EM, Szeto WY, Webb JG, Moses JW, Smith CR, Williams MR, Leon MB, Kodali SK, PARTNER Publications Office.
    JACC Cardiovasc Interv; 2015 Jan 23; 8(1 Pt A):60-9. PubMed ID: 25616819
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for permanent pacemaker implantation in patients receiving a balloon-expandable transcatheter aortic valve prosthesis.
    Droppa M, Rudolph TK, Baan J, Nielsen NE, Baumgartner H, Vendrik J, Froehlich M, Borst O, Wöhrle J, Gawaz M, Potratz P, Hack LP, Mauri V, Baranowski J, Bramlage P, Kurucova J, Thoenes M, Rottbauer W, Geisler T.
    Heart Vessels; 2020 Dec 23; 35(12):1735-1745. PubMed ID: 32591894
    [Abstract] [Full Text] [Related]

  • 17. Conduction Abnormalities and Pacemaker Implantations After SAPIEN 3 Vs SAPIEN XT Prosthesis Aortic Valve Implantation.
    Husser O, Kessler T, Burgdorf C, Templin C, Pellegrini C, Schneider S, Kasel AM, Kastrati A, Schunkert H, Hengstenberg C.
    Rev Esp Cardiol (Engl Ed); 2016 Feb 23; 69(2):141-8. PubMed ID: 26542175
    [Abstract] [Full Text] [Related]

  • 18. Conduction dynamics after transcatheter aortic valve implantation and implications for permanent pacemaker implantation and early discharge: the CONDUCT-study.
    van Gils L, Baart S, Kroon H, Rahhab Z, El Faquir N, Rodriguez Olivares R, Aga Y, Maugenest AM, Theuns DA, Boersma E, Szili Torok T, De Jaegere PP, Van Mieghem NM.
    Europace; 2018 Dec 01; 20(12):1981-1988. PubMed ID: 29688322
    [Abstract] [Full Text] [Related]

  • 19. Impact of the repositionable Evolut R CoreValve system on the need for a permanent pacemaker after transcatheter aortic valve implantation in patients with severe aortic stenosis.
    Ojeda S, Hidalgo F, Romero M, Mazuelos F, Suárez de Lezo J, Martín E, Lostalo A, Luque A, González R, Fernández A, López-Aguilera J, Segura J, Guerrero N, Pan M.
    Catheter Cardiovasc Interv; 2020 Mar 01; 95(4):783-790. PubMed ID: 31062927
    [Abstract] [Full Text] [Related]

  • 20. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B, Seeger J, Junker A, Rodewald C, Trepte U, Scharnbeck D, Rottbauer W, Wöhrle J.
    Arch Cardiovasc Dis; 2018 Mar 01; 111(8-9):470-479. PubMed ID: 29128473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.